Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

CV ansehen CV ausblenden

Aktuelle News & Insights

Technology, Media & Communications

Advising leading underwriting and risk analytics business, Envelop Risk, on its $130 million Series B financing

24. September 2021

von Ross McNaughton und Alex Dodds

Klicken Sie hier für Details
Life Sciences & Healthcare

Advising N+1 Singer on £25 million placing to drive digital transformation of healthcare systems

14. Juni 2021

von Ross McNaughton

Klicken Sie hier für Details
Gesellschaftsrecht/ M&A & Kapitalmärkte

Revolutionising access to biology with transformational acquisition by Nuclera

13. Mai 2021

von Ross McNaughton und Adrian Toutoungi

Klicken Sie hier für Details
Gesellschaftsrecht/ M&A & Kapitalmärkte

US and UK national security and investment – a joint discussion with CFIUS and BEIS

11. Mai 2021

von mehreren Autoren

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.